{'fraction_non_alphanumeric': 0.02676056338028169, 'fraction_numerical': 0.0, 'mean_word_length': 5.463636363636364, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Clinical trials probe new therapies for some difficult-to-treat cancers.

CHICAGO—Recent clinical studies have generated promising results for the treatment of cancers that have traditionally posed significant challenges for oncologists. Findings from trials of experimental therapies for pancreatic, kidney, and endometrial cancer were presented here in June at the annual meeting of the American Society of Clinical Oncology. “These studies identify promising new treatments for patients with some of the most hard-to-treat cancers, and new ways to improve patient symptoms and side effects of treatments,” said Nicholas Petrelli, MD, medical director of the Helen F. Graham Cancer Center in Wilmington, Del.